PT Bundamedik Tbk (IDX: BMHS)
288.00
-6.00 (-2.04%)
Sep 10, 2024, 4:11 PM WIB
PT Bundamedik Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Revenue | 1,550,932 | 1,488,197 | 1,658,688 | 1,890,800 | 1,148,144 | 964,893 | Upgrade
|
Revenue Growth (YoY) | -0.93% | -10.28% | -12.28% | 64.68% | 18.99% | 13.22% | Upgrade
|
Cost of Revenue | 841,355 | 813,590 | 915,848 | 942,939 | 679,913 | 519,838 | Upgrade
|
Gross Profit | 709,577 | 674,607 | 742,840 | 947,861 | 468,231 | 445,055 | Upgrade
|
Selling, General & Admin | 474,063 | 463,169 | 415,685 | 405,196 | 249,243 | 265,628 | Upgrade
|
Other Operating Expenses | 15,226 | 10,176 | 2,196 | -3,721 | -6,891 | 35,482 | Upgrade
|
Operating Expenses | 602,843 | 586,899 | 526,419 | 472,885 | 300,642 | 346,111 | Upgrade
|
Operating Income | 106,734 | 87,709 | 216,422 | 474,976 | 167,590 | 98,944 | Upgrade
|
Interest Expense | -58,526 | -53,290 | -42,694 | -20,031 | -43,633 | -56,148 | Upgrade
|
Interest & Investment Income | 11,101 | 8,424 | 8,363 | 10,178 | 4,734 | 2,041 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | 25,816 | 4,545 | Upgrade
|
Other Non Operating Income (Expenses) | -5,007 | -4,473 | -4,425 | -7,984 | -9,486 | -2,245 | Upgrade
|
EBT Excluding Unusual Items | 54,301 | 38,369 | 177,665 | 457,139 | 145,020 | 47,137 | Upgrade
|
Gain (Loss) on Sale of Assets | 1,954 | 1,954 | -874.84 | - | -28.33 | -23.19 | Upgrade
|
Pretax Income | 56,255 | 40,323 | 176,790 | 457,139 | 144,992 | 47,114 | Upgrade
|
Income Tax Expense | 27,619 | 24,094 | 47,858 | 102,490 | 26,532 | 15,797 | Upgrade
|
Earnings From Continuing Operations | 28,636 | 16,229 | 128,932 | 354,649 | 118,460 | 31,317 | Upgrade
|
Minority Interest in Earnings | -14,471 | -8,768 | -45,704 | -140,160 | -29,669 | -11,422 | Upgrade
|
Net Income | 14,165 | 7,461 | 83,228 | 214,489 | 88,791 | 19,895 | Upgrade
|
Net Income to Common | 14,165 | 7,461 | 83,228 | 214,489 | 88,791 | 19,895 | Upgrade
|
Net Income Growth | -58.37% | -91.04% | -61.20% | 141.57% | 346.30% | 287.97% | Upgrade
|
Shares Outstanding (Basic) | 8,603 | 8,603 | 8,603 | 8,603 | 2,077 | 50 | Upgrade
|
Shares Outstanding (Diluted) | 8,603 | 8,603 | 8,603 | 8,603 | 2,077 | 50 | Upgrade
|
Shares Change (YoY) | - | - | - | 314.14% | 4054.80% | - | Upgrade
|
EPS (Basic) | 1.65 | 0.87 | 9.67 | 24.93 | 42.74 | 397.89 | Upgrade
|
EPS (Diluted) | 1.65 | 0.87 | 9.67 | 24.93 | 42.74 | 397.89 | Upgrade
|
EPS Growth | -58.37% | -91.04% | -61.20% | -41.67% | -89.26% | 287.97% | Upgrade
|
Free Cash Flow | -218,820 | -157,915 | -170,646 | 51,263 | 140,752 | 17,214 | Upgrade
|
Free Cash Flow Per Share | -25.43 | -18.35 | -19.83 | 5.96 | 67.75 | 344.28 | Upgrade
|
Dividend Per Share | - | - | 1.500 | 2.557 | - | - | Upgrade
|
Dividend Growth | - | - | -41.34% | - | - | - | Upgrade
|
Gross Margin | 45.75% | 45.33% | 44.78% | 50.13% | 40.78% | 46.12% | Upgrade
|
Operating Margin | 6.88% | 5.89% | 13.05% | 25.12% | 14.60% | 10.25% | Upgrade
|
Profit Margin | 0.91% | 0.50% | 5.02% | 11.34% | 7.73% | 2.06% | Upgrade
|
Free Cash Flow Margin | -14.11% | -10.61% | -10.29% | 2.71% | 12.26% | 1.78% | Upgrade
|
EBITDA | 208,614 | 182,468 | 306,066 | 537,580 | 223,186 | 150,920 | Upgrade
|
EBITDA Margin | 13.45% | 12.26% | 18.45% | 28.43% | 19.44% | 15.64% | Upgrade
|
D&A For EBITDA | 101,880 | 94,759 | 89,644 | 62,604 | 55,596 | 51,976 | Upgrade
|
EBIT | 106,734 | 87,709 | 216,422 | 474,976 | 167,590 | 98,944 | Upgrade
|
EBIT Margin | 6.88% | 5.89% | 13.05% | 25.12% | 14.60% | 10.25% | Upgrade
|
Effective Tax Rate | 49.10% | 59.75% | 27.07% | 22.42% | 18.30% | 33.53% | Upgrade
|
Advertising Expenses | - | 26,906 | 31,959 | 33,182 | 9,925 | 7,549 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.